Re: CSRINDX JUL 97

["Mark F. Hardy" <aettper7@xxxxxxxxxxxxxxxxxxxxxxxxxx>]

------ =_NextPart_000_01BC84D7.589005C0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit



-----Original Message-----
From:   Joe Bruman [SMTP:jrbruman@xxxxxxxxxxxxx]
Sent:   Sunday, June 29, 1997 6:16 AM
To:     Multiple recipients of list PARKINSN
Subject:        CSRINDX JUL 97

I N D E X ,   C U R R E N T   S C I E N C E   R E V I E W S

I've never done this before, so please walk me thru the process.
I would like information on Permax and I see the following articles
on such:

Agonists, action       May 95 Neur                1995;45S3:S5
Pergolide (Permax)     May 95 Neur                1995;45S3:S5
     "                 May 95 Neur                1995;45S3:S13-S21
     "                 May 95 Neur                1995;45S3:S22-S27


thanks, Mark Hardy
              aettper7@xxxxxxxxxxxxxxxxxxxxxxxxxx
------ =_NextPart_000_01BC84D7.589005C0
Content-Type: application/ms-tnef
Content-Transfer-Encoding: 
=========================================================================
Date:         Sun, 29 Jun 1997 16:11:41 -0400
Reply-To:     Parkinson's Information Exchange <PARKINSN@xxxxxxxxxxxxxxxxxxxx>
Sender:       Parkinson's Information Exchange <PARKINSN@xxxxxxxxxxxxxxxxxxxx>
From:         Don Mckinley <flash@xxxxxxxxx>
Subject:      another test...

test..test..